Pharmacology Faculty

Learn more about Kent State’s Pharmacology Program faculty today.  All of our faculty members have extensive educational backgrounds that make them exceptional sources of industry information and insights. Feel free to contact any of the Pharmacology Program faculty listed below by clicking on the link to their email address.

Once you’ve read about the Pharmacology Program faculty members, be sure to learn more about the Pharmacology Program itself. If you have any questions or would like additional information, please contact the School of Biomedical Sciences.

Name Email Campus Specialty
Soumitra Basu

Kent Molecular basis of RNA structure and function, drug design. More on Basu
William Chilian

NEOMED Angiogenesis, arteriogenesis, regulation of coronary blood flow, heart failure, stem cells, regenerative medicine. More on Chilian
Lique Coolen

Kent Mechanisms by which spinal cord injury affects urogenital and sexual function, neurobiology of addiction and understanding neural circuits that mediate female reproductive function and dysfunction. More on Coolen
Mark Dalman

Kent More on Dalman
Altaf Darvesh

NEOMED Development of antioxidant and anti-inflammatory strategies for neoplastic an neurodegenerative diseases, as well as psychiatric disorders.  More on Darvesh
Dimitrios Davalos

CCF The Dimitrios Davalos lab studies the interactions between blood vessels, neurons and microglia in health and disease. More on Davalos
Christine Dengler-Crish

NEOMED Early disease mechanisms in dementia; sensory system disruptions and homeostatic dysregulation in Alzheimer's disease. More on Crish
Feng Dong


More on Dong
Jessica Ferrell

NEOMED More on Ferrell
Sheila Fleming

NEOMED More on Fleming
T. Lee Gilman

Kent Influences of diet, stress and genetic variation on emotions, behavior, and overall brain & body health.  More on Gilman.
Adam Goodwill

NEOMED Mechanisms of coronary flow control, studies of cardiac function and identification of cardioprotective pathways. More on Goodwill
Tariq Haqqi

NEOMED More on Haqqi
Takhar Kasumov

NEOMED More on Kasumov
Yoon-Kwang Lee

NEOMED Structure and regulation of nuclear hormone receptors. More on Lee
Yong Lu

NEOMED Neurotransmitter systems, GABA, glutamate, audition. More on Lu
Jeffrey Mellott

NEOMED Age-related changes to inhibitory circuitry in the auditory pathways. More on Mellott
Devin Mueller

Kent Neural mechanisms of learning and memory that underlie drug use and emotional regulation. More on Mueller
Vahagn Ohanyan

NEOMED More on Ohanyan
Heather O'Leary

NEOMED More on O'Leary
Moses Oyewumi

NEOMED More on Oyewumi
Priya Raman

NEOMED My lab is interested in the cellular and molecular mechanisms underlying vascular complications and Alzheimer's disease-related dementia associated with diabetes and obesity. We are studying the role of a post-translational protein modification (O-Glycosylation) and a proatherogenic matricellular protein (Thrombospondin-1) in vascular smooth muscle cell phenotypic changes and seeking to understand how targets contributed to vascular and cognitive anomalies in metabolic disorders. More on Raman
Erin Reed-Geaghan


My lab is interested in the role of the immune system in Alzheimer’s disease (AD). Specifically, we seek to understand the ways in which the brain’s resident immune cells, microglia, contribute to the neuroinflammatory processes driving neurodegeneration. We believe microglia from men and women respond differently in AD, contributing to the sex differences in disease onset and progression, and we’re working on identifying the reasons for these differences. We are also interested in how these cells communicate with the circulating peripheral immune system, and the ways in which these interactions affect disease progression. More on Reed-Geaghan

Prabodh Sadana

NEOMED Hormonal regulation of lipid metabolism. More on Sadana
Thorsten-Lars Schmidt

Kent DNA nanotechnology-based tools and materials for single-molecule biophysics and nanomedicine.  More on Schmidt
Xinwen Wang


One size does not fit all. For many patients, standard drug treatment might not work or even trigger life-threatening adverse reactions. There is an urgent clinical need to provide tailored therapy for patients. Our laboratory focuses on applying pharmaco-omics tools (i.e. pharmacogenomics, proteomics and metabolomics) to identify both genetic and non-genetic factors contributing to the interindividual variability related to disease risks and drug therapies. Our research is expected to improve the efficacy and safety of drugs by identifying biomarkers that can predict individual drug responses, revealing novel drug targets and translating these findings into clinical precision pharmacotherapy. More on Wang

Bradley Winters

NEOMED Cellular neurophysiology of brainstem sound localization circuits that process timing and intensity differences between the two ears. More on Winters
Liya Yin

NEOMED More on Yin
Yanqiao Zhang

NEOMED Regulation of lipid and glucose metabolism under normal and disease conditions.  More on Zhang
Yaorong Zheng

Kent More on Zheng